The present invention relates to a mycobacterial deoxyribonucleic acid (B-DNA)
preserved and complexed on the mycobacterial cell wall (BCC) and a pharmaceutically
acceptable carrier, wherein the BCC is effective in treating an inflammation in
an animal having an inflammation. More particularly, the present invention relates
to a Mycobacterium phlei deoxyribonucleic acid (M-DNA) preserved and complexed
on Mycobacterium phlei cell wall (MCC) and a pharmaceutically acceptable
carrier, wherein the MCC is effective in treating an inflammation in an animal
having an inflammation.
